Welcome to kongre.net
Speaker
Modality Intelligence Lead, Oncology Research Intelligence, Astellas Pharma
Yutaka Matsuda, Modality Intelligence Lead, Oncology Research Intelligence at Astellas Pharma, spoke at 17th World ADC San Diego (San Diego, United States of America, 12–15 Oct 2026) in the session “Encompassing the Breadth of Conjugation Approaches to Optimize Bioconjugate Design & Performance Across Traditional, Dual Payload ADCs & Beyond”.
12–15 Oct 2026San Diego, United States of America
Chief Scientific Officer, Iksuda Therapeutics
Associate Director, Medicinal Chemistry, AstraZeneca
Senior Director, Chemistry, Sutro Biopharma
Chief Scientific Officer, Callio Therapeutics
President & Founder, Bramhill Biologics Consulting
Executive Director, Product Stewardship Lead, AstraZeneca
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Yutaka Matsuda, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].